GENOMEMEDICINE . BIOMEDCENTRAL . COM {
}
Title:
Neutrophil extracellular traps have auto-catabolic activity and produce mononucleosome-associated circulating DNA | Genome Medicine | Full Text
Description:
Background As circulating DNA (cirDNA) is mainly detected as mononucleosome-associated circulating DNA (mono-N cirDNA) in blood, apoptosis has until now been considered as the main source of cirDNA. The mechanism of cirDNA release into the circulation, however, is still not fully understood. This work addresses that knowledge gap, working from the postulate that neutrophil extracellular traps (NET) may be a source of cirDNA, and by investigating whether NET may directly produce mono-N cirDNA. Methods We studied (1) the in vitro kinetics of cell derived genomic high molecular weight (gHMW) DNA degradation in serum; (2) the production of extracellular DNA and NET markers such as neutrophil elastase (NE) and myeloperoxidase (MPO) by ex vivo activated neutrophils; and (3) the in vitro NET degradation in serum; for this, we exploited the synergistic analytical information provided by specifically quantifying DNA by qPCR, and used shallow WGS and capillary electrophoresis to perform fragment size analysis. We also performed an in vivo study in knockout mice, and an in vitro study of gHMW DNA degradation, to elucidate the role of NE and MPO in effecting DNA degradation and fragmentation. We then compared the NET-associated markers and fragmentation size profiles of cirDNA in plasma obtained from patients with inflammatory diseases found to be associated with NET formation and high levels of cirDNA (COVID-19, N = 28; systemic lupus erythematosus, N = 10; metastatic colorectal cancer, N = 10; and from healthy individuals, N = 114). Results Our studies reveal that gHMW DNA degradation in serum results in the accumulation of mono-N DNA (81.3% of the remaining DNA following 24 h incubation in serum corresponded to mono-N DNA); “ex vivo” NET formation, as demonstrated by a concurrent 5-, 5-, and 35-fold increase of NE, MPO, and cell-free DNA (cfDNA) concentration in PMA-activated neutrophil culture supernatant, leads to the release of high molecular weight DNA that degrades down to mono-N in serum; NET mainly in the form of gHMW DNA generate mono-N cirDNA (2 and 41% of the remaining DNA after 2 h in serum corresponded to 1–10 kbp fragments and mono-N, respectively) independent of any cellular process when degraded in serum; NE and MPO may contribute synergistically to NET autocatabolism, resulting in a 25-fold decrease in total DNA concentration and a DNA fragment size profile similar to that observed from cirDNA following 8 h incubation with both NE and MPO; the cirDNA size profile of NE KO mice significantly differed from that of the WT, suggesting NE involvement in DNA degradation; and a significant increase in the levels of NE, MPO, and cirDNA was detected in plasma samples from lupus, COVID-19, and mCRC, showing a high correlation with these inflammatory diseases, while no correlation of NE and MPO with cirDNA was found in HI. Conclusions Our work describes the mechanisms by which NET and cirDNA are linked. In doing so, we demonstrate that NET are a major source of mono-N cirDNA independent of apoptosis and establish a new paradigm of the mechanisms of cirDNA release in normal and pathological conditions. We also demonstrate a link between immune response and cirDNA.
Website Age:
25 years and 10 months (reg. 1999-08-06).
Matching Content Categories {📚}
- Telecommunications
- Social Networks
- Personal Finance
Content Management System {📝}
What CMS is genomemedicine.biomedcentral.com built with?
Custom-built
No common CMS systems were detected on Genomemedicine.biomedcentral.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of genomemedicine.biomedcentral.com audience?
🚄 Respectable Traffic: 10k - 20k visitors per month
Based on our best estimate, this website will receive around 10,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Genomemedicine.biomedcentral.com Make Money? {💸}
Display Ads {🎯}
The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.
Ads are managed by yourbow.com. Particular relationships are as follows:
Direct Advertisers (3)
yourbow.com, google.com, doceree.comHow Much Does Genomemedicine.biomedcentral.com Make? {💰}
Display Ads {🎯}
$190 per month
Estimations show Genomemedicine.biomedcentral.com's display ad online revenue falls between $126 and $347 per month.
Keywords {🔍}
dna, cookies, bmc, ghmw, privacy, neutrophil, degradation, presence, mpo, page, analysis, data, incubation, serum, elastase, myeloperoxidase, nempo, cfdna, optional, content, personal, parties, policy, information, manage, genome, medicine, plasma, control, size, fractions, article, contact, editing, authors, choice, essential, make, site, function, advertising, personalisation, usage, social, media, accepting, consent, processing, including, transfers,
Topics {✒️}
authors scientific editing privacy choices/manage cookies bmc 1756-994x contact ghmw dna samples ghmw dna degradation european economic area auto-catabolic activity state privacy rights neutrophil extracellular traps ghmw dna incubation accepting optional cookies cfdna size profiles manage preferences ghmw dna personal data total dna optional cookies data protection essential cookies cookies skip size profile cookies policy privacy policy privacy statement cfdna fractions neutrophil elastase usage analysis social media varying standards produce mononucleosome cell lysate blood fluids general enquiries preference centre springer nature content degradation + ne/mpo choices privacy analysis incubation ne mpo + ne + mpo choice make site
Schema {🗺️}
WebPage:
mainEntity:
headline:Neutrophil extracellular traps have auto-catabolic activity and produce mononucleosome-associated circulating DNA
description:As circulating DNA (cirDNA) is mainly detected as mononucleosome-associated circulating DNA (mono-N cirDNA) in blood, apoptosis has until now been considered as the main source of cirDNA. The mechanism of cirDNA release into the circulation, however, is still not fully understood. This work addresses that knowledge gap, working from the postulate that neutrophil extracellular traps (NET) may be a source of cirDNA, and by investigating whether NET may directly produce mono-N cirDNA. We studied (1) the in vitro kinetics of cell derived genomic high molecular weight (gHMW) DNA degradation in serum; (2) the production of extracellular DNA and NET markers such as neutrophil elastase (NE) and myeloperoxidase (MPO) by ex vivo activated neutrophils; and (3) the in vitro NET degradation in serum; for this, we exploited the synergistic analytical information provided by specifically quantifying DNA by qPCR, and used shallow WGS and capillary electrophoresis to perform fragment size analysis. We also performed an in vivo study in knockout mice, and an in vitro study of gHMW DNA degradation, to elucidate the role of NE and MPO in effecting DNA degradation and fragmentation. We then compared the NET-associated markers and fragmentation size profiles of cirDNA in plasma obtained from patients with inflammatory diseases found to be associated with NET formation and high levels of cirDNA (COVID-19, N = 28; systemic lupus erythematosus, N = 10; metastatic colorectal cancer, N = 10; and from healthy individuals, N = 114). Our studies reveal that gHMW DNA degradation in serum results in the accumulation of mono-N DNA (81.3% of the remaining DNA following 24 h incubation in serum corresponded to mono-N DNA); “ex vivo” NET formation, as demonstrated by a concurrent 5-, 5-, and 35-fold increase of NE, MPO, and cell-free DNA (cfDNA) concentration in PMA-activated neutrophil culture supernatant, leads to the release of high molecular weight DNA that degrades down to mono-N in serum; NET mainly in the form of gHMW DNA generate mono-N cirDNA (2 and 41% of the remaining DNA after 2 h in serum corresponded to 1–10 kbp fragments and mono-N, respectively) independent of any cellular process when degraded in serum; NE and MPO may contribute synergistically to NET autocatabolism, resulting in a 25-fold decrease in total DNA concentration and a DNA fragment size profile similar to that observed from cirDNA following 8 h incubation with both NE and MPO; the cirDNA size profile of NE KO mice significantly differed from that of the WT, suggesting NE involvement in DNA degradation; and a significant increase in the levels of NE, MPO, and cirDNA was detected in plasma samples from lupus, COVID-19, and mCRC, showing a high correlation with these inflammatory diseases, while no correlation of NE and MPO with cirDNA was found in HI. Our work describes the mechanisms by which NET and cirDNA are linked. In doing so, we demonstrate that NET are a major source of mono-N cirDNA independent of apoptosis and establish a new paradigm of the mechanisms of cirDNA release in normal and pathological conditions. We also demonstrate a link between immune response and cirDNA.
datePublished:2022-11-28T00:00:00Z
dateModified:2022-11-28T00:00:00Z
pageStart:1
pageEnd:24
license:http://creativecommons.org/publicdomain/zero/1.0/
sameAs:https://doi.org/10.1186/s13073-022-01125-8
keywords:
Circulating DNA
Elastase
Myeloperoxidase
Neutrophil
NET
Nucleosome
Human Genetics
Metabolomics
Bioinformatics
Medicine/Public Health
general
Cancer Research
Systems Biology
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13073-022-01125-8/MediaObjects/13073_2022_1125_Fig1_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13073-022-01125-8/MediaObjects/13073_2022_1125_Fig2_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13073-022-01125-8/MediaObjects/13073_2022_1125_Fig3_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13073-022-01125-8/MediaObjects/13073_2022_1125_Fig4_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13073-022-01125-8/MediaObjects/13073_2022_1125_Fig5_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13073-022-01125-8/MediaObjects/13073_2022_1125_Fig6_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13073-022-01125-8/MediaObjects/13073_2022_1125_Fig7_HTML.png
isPartOf:
name:Genome Medicine
issn:
1756-994X
volumeNumber:14
type:
Periodical
PublicationVolume
publisher:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Ekaterina Pisareva
affiliation:
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier
address:
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, Montpellier, France
type:PostalAddress
type:Organization
type:Person
name:Lucia Mihalovičová
affiliation:
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier
address:
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, Montpellier, France
type:PostalAddress
type:Organization
name:Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University
address:
name:Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia
type:PostalAddress
type:Organization
type:Person
name:Brice Pastor
affiliation:
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier
address:
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, Montpellier, France
type:PostalAddress
type:Organization
type:Person
name:Andrei Kudriavtsev
affiliation:
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier
address:
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, Montpellier, France
type:PostalAddress
type:Organization
type:Person
name:Alexia Mirandola
affiliation:
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier
address:
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, Montpellier, France
type:PostalAddress
type:Organization
type:Person
name:Thibault Mazard
affiliation:
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier
address:
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, Montpellier, France
type:PostalAddress
type:Organization
name:Montpellier Cancer Institute (ICM)
address:
name:Department of Medical Oncology, Montpellier Cancer Institute (ICM), Montpellier, France
type:PostalAddress
type:Organization
type:Person
name:Stephanie Badiou
affiliation:
name:PhyMedExp, Université de Montpellier, INSERM, CNRS, CHU de Montpellier
address:
name:Laboratoire de Biochimie Et Hormonologie, PhyMedExp, Université de Montpellier, INSERM, CNRS, CHU de Montpellier, Montpellier, France
type:PostalAddress
type:Organization
type:Person
name:Ulrich Maus
affiliation:
name:Hannover Medical School, and German Center for Lung Research, Partner Site BREATH (Biomedical Research in Endstage and Obstructive Lung Disease)
address:
name:Division of Experimental Pneumology, Hannover Medical School, and German Center for Lung Research, Partner Site BREATH (Biomedical Research in Endstage and Obstructive Lung Disease), Hannover, Germany
type:PostalAddress
type:Organization
type:Person
name:Lena Ostermann
affiliation:
name:Hannover Medical School, and German Center for Lung Research, Partner Site BREATH (Biomedical Research in Endstage and Obstructive Lung Disease)
address:
name:Division of Experimental Pneumology, Hannover Medical School, and German Center for Lung Research, Partner Site BREATH (Biomedical Research in Endstage and Obstructive Lung Disease), Hannover, Germany
type:PostalAddress
type:Organization
type:Person
name:Julia Weinmann-Menke
affiliation:
name:University Medical Center Mainz
address:
name:Department of Rheumatology and Nephrology, University Medical Center Mainz, Mainz, Germany
type:PostalAddress
type:Organization
type:Person
name:Elmo W. I. Neuberger
affiliation:
name:University of Mainz
address:
name:Department of Sports Medicine, University of Mainz, Mainz, Germany
type:PostalAddress
type:Organization
type:Person
name:Perikles Simon
affiliation:
name:University of Mainz
address:
name:Department of Sports Medicine, University of Mainz, Mainz, Germany
type:PostalAddress
type:Organization
type:Person
name:Alain R. Thierry
url:http://orcid.org/0000-0002-4632-5404
affiliation:
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier
address:
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, Montpellier, France
type:PostalAddress
type:Organization
name:Montpellier Cancer Institute (ICM)
address:
name:Department of Medical Oncology, Montpellier Cancer Institute (ICM), Montpellier, France
type:PostalAddress
type:Organization
name:Montpellier Cancer Institute (ICM)
address:
name:Montpellier Cancer Institute (ICM), Montpellier, France
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:1
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Neutrophil extracellular traps have auto-catabolic activity and produce mononucleosome-associated circulating DNA
description:As circulating DNA (cirDNA) is mainly detected as mononucleosome-associated circulating DNA (mono-N cirDNA) in blood, apoptosis has until now been considered as the main source of cirDNA. The mechanism of cirDNA release into the circulation, however, is still not fully understood. This work addresses that knowledge gap, working from the postulate that neutrophil extracellular traps (NET) may be a source of cirDNA, and by investigating whether NET may directly produce mono-N cirDNA. We studied (1) the in vitro kinetics of cell derived genomic high molecular weight (gHMW) DNA degradation in serum; (2) the production of extracellular DNA and NET markers such as neutrophil elastase (NE) and myeloperoxidase (MPO) by ex vivo activated neutrophils; and (3) the in vitro NET degradation in serum; for this, we exploited the synergistic analytical information provided by specifically quantifying DNA by qPCR, and used shallow WGS and capillary electrophoresis to perform fragment size analysis. We also performed an in vivo study in knockout mice, and an in vitro study of gHMW DNA degradation, to elucidate the role of NE and MPO in effecting DNA degradation and fragmentation. We then compared the NET-associated markers and fragmentation size profiles of cirDNA in plasma obtained from patients with inflammatory diseases found to be associated with NET formation and high levels of cirDNA (COVID-19, N = 28; systemic lupus erythematosus, N = 10; metastatic colorectal cancer, N = 10; and from healthy individuals, N = 114). Our studies reveal that gHMW DNA degradation in serum results in the accumulation of mono-N DNA (81.3% of the remaining DNA following 24 h incubation in serum corresponded to mono-N DNA); “ex vivo” NET formation, as demonstrated by a concurrent 5-, 5-, and 35-fold increase of NE, MPO, and cell-free DNA (cfDNA) concentration in PMA-activated neutrophil culture supernatant, leads to the release of high molecular weight DNA that degrades down to mono-N in serum; NET mainly in the form of gHMW DNA generate mono-N cirDNA (2 and 41% of the remaining DNA after 2 h in serum corresponded to 1–10 kbp fragments and mono-N, respectively) independent of any cellular process when degraded in serum; NE and MPO may contribute synergistically to NET autocatabolism, resulting in a 25-fold decrease in total DNA concentration and a DNA fragment size profile similar to that observed from cirDNA following 8 h incubation with both NE and MPO; the cirDNA size profile of NE KO mice significantly differed from that of the WT, suggesting NE involvement in DNA degradation; and a significant increase in the levels of NE, MPO, and cirDNA was detected in plasma samples from lupus, COVID-19, and mCRC, showing a high correlation with these inflammatory diseases, while no correlation of NE and MPO with cirDNA was found in HI. Our work describes the mechanisms by which NET and cirDNA are linked. In doing so, we demonstrate that NET are a major source of mono-N cirDNA independent of apoptosis and establish a new paradigm of the mechanisms of cirDNA release in normal and pathological conditions. We also demonstrate a link between immune response and cirDNA.
datePublished:2022-11-28T00:00:00Z
dateModified:2022-11-28T00:00:00Z
pageStart:1
pageEnd:24
license:http://creativecommons.org/publicdomain/zero/1.0/
sameAs:https://doi.org/10.1186/s13073-022-01125-8
keywords:
Circulating DNA
Elastase
Myeloperoxidase
Neutrophil
NET
Nucleosome
Human Genetics
Metabolomics
Bioinformatics
Medicine/Public Health
general
Cancer Research
Systems Biology
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13073-022-01125-8/MediaObjects/13073_2022_1125_Fig1_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13073-022-01125-8/MediaObjects/13073_2022_1125_Fig2_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13073-022-01125-8/MediaObjects/13073_2022_1125_Fig3_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13073-022-01125-8/MediaObjects/13073_2022_1125_Fig4_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13073-022-01125-8/MediaObjects/13073_2022_1125_Fig5_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13073-022-01125-8/MediaObjects/13073_2022_1125_Fig6_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13073-022-01125-8/MediaObjects/13073_2022_1125_Fig7_HTML.png
isPartOf:
name:Genome Medicine
issn:
1756-994X
volumeNumber:14
type:
Periodical
PublicationVolume
publisher:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Ekaterina Pisareva
affiliation:
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier
address:
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, Montpellier, France
type:PostalAddress
type:Organization
type:Person
name:Lucia Mihalovičová
affiliation:
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier
address:
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, Montpellier, France
type:PostalAddress
type:Organization
name:Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University
address:
name:Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia
type:PostalAddress
type:Organization
type:Person
name:Brice Pastor
affiliation:
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier
address:
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, Montpellier, France
type:PostalAddress
type:Organization
type:Person
name:Andrei Kudriavtsev
affiliation:
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier
address:
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, Montpellier, France
type:PostalAddress
type:Organization
type:Person
name:Alexia Mirandola
affiliation:
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier
address:
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, Montpellier, France
type:PostalAddress
type:Organization
type:Person
name:Thibault Mazard
affiliation:
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier
address:
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, Montpellier, France
type:PostalAddress
type:Organization
name:Montpellier Cancer Institute (ICM)
address:
name:Department of Medical Oncology, Montpellier Cancer Institute (ICM), Montpellier, France
type:PostalAddress
type:Organization
type:Person
name:Stephanie Badiou
affiliation:
name:PhyMedExp, Université de Montpellier, INSERM, CNRS, CHU de Montpellier
address:
name:Laboratoire de Biochimie Et Hormonologie, PhyMedExp, Université de Montpellier, INSERM, CNRS, CHU de Montpellier, Montpellier, France
type:PostalAddress
type:Organization
type:Person
name:Ulrich Maus
affiliation:
name:Hannover Medical School, and German Center for Lung Research, Partner Site BREATH (Biomedical Research in Endstage and Obstructive Lung Disease)
address:
name:Division of Experimental Pneumology, Hannover Medical School, and German Center for Lung Research, Partner Site BREATH (Biomedical Research in Endstage and Obstructive Lung Disease), Hannover, Germany
type:PostalAddress
type:Organization
type:Person
name:Lena Ostermann
affiliation:
name:Hannover Medical School, and German Center for Lung Research, Partner Site BREATH (Biomedical Research in Endstage and Obstructive Lung Disease)
address:
name:Division of Experimental Pneumology, Hannover Medical School, and German Center for Lung Research, Partner Site BREATH (Biomedical Research in Endstage and Obstructive Lung Disease), Hannover, Germany
type:PostalAddress
type:Organization
type:Person
name:Julia Weinmann-Menke
affiliation:
name:University Medical Center Mainz
address:
name:Department of Rheumatology and Nephrology, University Medical Center Mainz, Mainz, Germany
type:PostalAddress
type:Organization
type:Person
name:Elmo W. I. Neuberger
affiliation:
name:University of Mainz
address:
name:Department of Sports Medicine, University of Mainz, Mainz, Germany
type:PostalAddress
type:Organization
type:Person
name:Perikles Simon
affiliation:
name:University of Mainz
address:
name:Department of Sports Medicine, University of Mainz, Mainz, Germany
type:PostalAddress
type:Organization
type:Person
name:Alain R. Thierry
url:http://orcid.org/0000-0002-4632-5404
affiliation:
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier
address:
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, Montpellier, France
type:PostalAddress
type:Organization
name:Montpellier Cancer Institute (ICM)
address:
name:Department of Medical Oncology, Montpellier Cancer Institute (ICM), Montpellier, France
type:PostalAddress
type:Organization
name:Montpellier Cancer Institute (ICM)
address:
name:Montpellier Cancer Institute (ICM), Montpellier, France
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:1
["Periodical","PublicationVolume"]:
name:Genome Medicine
issn:
1756-994X
volumeNumber:14
Organization:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier
address:
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, Montpellier, France
type:PostalAddress
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier
address:
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, Montpellier, France
type:PostalAddress
name:Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University
address:
name:Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia
type:PostalAddress
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier
address:
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, Montpellier, France
type:PostalAddress
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier
address:
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, Montpellier, France
type:PostalAddress
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier
address:
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, Montpellier, France
type:PostalAddress
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier
address:
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, Montpellier, France
type:PostalAddress
name:Montpellier Cancer Institute (ICM)
address:
name:Department of Medical Oncology, Montpellier Cancer Institute (ICM), Montpellier, France
type:PostalAddress
name:PhyMedExp, Université de Montpellier, INSERM, CNRS, CHU de Montpellier
address:
name:Laboratoire de Biochimie Et Hormonologie, PhyMedExp, Université de Montpellier, INSERM, CNRS, CHU de Montpellier, Montpellier, France
type:PostalAddress
name:Hannover Medical School, and German Center for Lung Research, Partner Site BREATH (Biomedical Research in Endstage and Obstructive Lung Disease)
address:
name:Division of Experimental Pneumology, Hannover Medical School, and German Center for Lung Research, Partner Site BREATH (Biomedical Research in Endstage and Obstructive Lung Disease), Hannover, Germany
type:PostalAddress
name:Hannover Medical School, and German Center for Lung Research, Partner Site BREATH (Biomedical Research in Endstage and Obstructive Lung Disease)
address:
name:Division of Experimental Pneumology, Hannover Medical School, and German Center for Lung Research, Partner Site BREATH (Biomedical Research in Endstage and Obstructive Lung Disease), Hannover, Germany
type:PostalAddress
name:University Medical Center Mainz
address:
name:Department of Rheumatology and Nephrology, University Medical Center Mainz, Mainz, Germany
type:PostalAddress
name:University of Mainz
address:
name:Department of Sports Medicine, University of Mainz, Mainz, Germany
type:PostalAddress
name:University of Mainz
address:
name:Department of Sports Medicine, University of Mainz, Mainz, Germany
type:PostalAddress
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier
address:
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, Montpellier, France
type:PostalAddress
name:Montpellier Cancer Institute (ICM)
address:
name:Department of Medical Oncology, Montpellier Cancer Institute (ICM), Montpellier, France
type:PostalAddress
name:Montpellier Cancer Institute (ICM)
address:
name:Montpellier Cancer Institute (ICM), Montpellier, France
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Ekaterina Pisareva
affiliation:
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier
address:
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, Montpellier, France
type:PostalAddress
type:Organization
name:Lucia Mihalovičová
affiliation:
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier
address:
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, Montpellier, France
type:PostalAddress
type:Organization
name:Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University
address:
name:Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia
type:PostalAddress
type:Organization
name:Brice Pastor
affiliation:
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier
address:
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, Montpellier, France
type:PostalAddress
type:Organization
name:Andrei Kudriavtsev
affiliation:
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier
address:
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, Montpellier, France
type:PostalAddress
type:Organization
name:Alexia Mirandola
affiliation:
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier
address:
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, Montpellier, France
type:PostalAddress
type:Organization
name:Thibault Mazard
affiliation:
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier
address:
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, Montpellier, France
type:PostalAddress
type:Organization
name:Montpellier Cancer Institute (ICM)
address:
name:Department of Medical Oncology, Montpellier Cancer Institute (ICM), Montpellier, France
type:PostalAddress
type:Organization
name:Stephanie Badiou
affiliation:
name:PhyMedExp, Université de Montpellier, INSERM, CNRS, CHU de Montpellier
address:
name:Laboratoire de Biochimie Et Hormonologie, PhyMedExp, Université de Montpellier, INSERM, CNRS, CHU de Montpellier, Montpellier, France
type:PostalAddress
type:Organization
name:Ulrich Maus
affiliation:
name:Hannover Medical School, and German Center for Lung Research, Partner Site BREATH (Biomedical Research in Endstage and Obstructive Lung Disease)
address:
name:Division of Experimental Pneumology, Hannover Medical School, and German Center for Lung Research, Partner Site BREATH (Biomedical Research in Endstage and Obstructive Lung Disease), Hannover, Germany
type:PostalAddress
type:Organization
name:Lena Ostermann
affiliation:
name:Hannover Medical School, and German Center for Lung Research, Partner Site BREATH (Biomedical Research in Endstage and Obstructive Lung Disease)
address:
name:Division of Experimental Pneumology, Hannover Medical School, and German Center for Lung Research, Partner Site BREATH (Biomedical Research in Endstage and Obstructive Lung Disease), Hannover, Germany
type:PostalAddress
type:Organization
name:Julia Weinmann-Menke
affiliation:
name:University Medical Center Mainz
address:
name:Department of Rheumatology and Nephrology, University Medical Center Mainz, Mainz, Germany
type:PostalAddress
type:Organization
name:Elmo W. I. Neuberger
affiliation:
name:University of Mainz
address:
name:Department of Sports Medicine, University of Mainz, Mainz, Germany
type:PostalAddress
type:Organization
name:Perikles Simon
affiliation:
name:University of Mainz
address:
name:Department of Sports Medicine, University of Mainz, Mainz, Germany
type:PostalAddress
type:Organization
name:Alain R. Thierry
url:http://orcid.org/0000-0002-4632-5404
affiliation:
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier
address:
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, Montpellier, France
type:PostalAddress
type:Organization
name:Montpellier Cancer Institute (ICM)
address:
name:Department of Medical Oncology, Montpellier Cancer Institute (ICM), Montpellier, France
type:PostalAddress
type:Organization
name:Montpellier Cancer Institute (ICM)
address:
name:Montpellier Cancer Institute (ICM), Montpellier, France
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, Montpellier, France
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, Montpellier, France
name:Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, Montpellier, France
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, Montpellier, France
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, Montpellier, France
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, Montpellier, France
name:Department of Medical Oncology, Montpellier Cancer Institute (ICM), Montpellier, France
name:Laboratoire de Biochimie Et Hormonologie, PhyMedExp, Université de Montpellier, INSERM, CNRS, CHU de Montpellier, Montpellier, France
name:Division of Experimental Pneumology, Hannover Medical School, and German Center for Lung Research, Partner Site BREATH (Biomedical Research in Endstage and Obstructive Lung Disease), Hannover, Germany
name:Division of Experimental Pneumology, Hannover Medical School, and German Center for Lung Research, Partner Site BREATH (Biomedical Research in Endstage and Obstructive Lung Disease), Hannover, Germany
name:Department of Rheumatology and Nephrology, University Medical Center Mainz, Mainz, Germany
name:Department of Sports Medicine, University of Mainz, Mainz, Germany
name:Department of Sports Medicine, University of Mainz, Mainz, Germany
name:IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, Montpellier, France
name:Department of Medical Oncology, Montpellier Cancer Institute (ICM), Montpellier, France
name:Montpellier Cancer Institute (ICM), Montpellier, France
External Links {🔗}(21)
- Find out how much https://www.biomedcentral.com/privacy-statement earns monthly
- https://www.biomedcentral.com income
- Find out how much https://www.biomedcentral.com/journals earns monthly
- What is the earnings of https://www.biomedcentral.com/getpublished?
- How much money does https://www.biomedcentral.com/about make?
- What's the income generated by https://www.biomedcentral.com/account each month?
- What's the total monthly financial gain of https://submission.springernature.com/new-submission/13073/3?
- How much income does https://blogs.biomedcentral.com/ have?
- How much does https://www.biomedcentral.com/login net monthly?
- How much does https://authorservices.springernature.com/go/sn/?utm_source=Website&utm_medium=BMC&utm_campaign=SNAS+Referrals+2022&utm_id=ref2022 pull in monthly?
- How much profit is https://www.biomedcentral.com/about/policies making per month?
- How profitable is https://www.biomedcentral.com/accessibility?
- What's the total monthly financial gain of https://www.biomedcentral.com/about/press-centre?
- How much does https://support.biomedcentral.com/support/home pull in?
- How much income does https://biomedcentral.typeform.com/to/VLXboo have?
- What's the income of https://www.biomedcentral.com/about/jobs?
- Earnings of http://www.weibo.com/biomedcentral
- Profit of https://www.biomedcentral.com/terms-and-conditions
- What's the monthly money flow for https://www.springernature.com/ccpa?
- What's the income generated by https://www.biomedcentral.com/cookies each month?
- Learn about the earnings of https://www.springernature.com
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Prism.js